US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist
  • 41.590
  • -0.250-0.60%
Close Apr 26 16:00 ET
  • 40.340
  • -1.250-3.01%
Post 19:57 ET
6.07BMarket Cap-16246P/E (TTM)

About Ionis Pharmaceuticals Company

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Company Profile

SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees927
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionispharm.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brett P. Monia, PhD
  • Chief Executive Officer and Director
  • 7.30M
  • Elizabeth L. Hougen
  • Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
  • 2.49M
  • Joseph T. Baroldi
  • Executive Vice President and Chief Business Officer
  • 4.02M
  • Eugene Schneider
  • Executive Vice President and Chief Clinical Development and Operations Officer
  • --
  • Patrick R. O'Neil, Esq.
  • Chief Legal Officer, General Counsel and Corporate Secretary
  • 3.46M
  • Dr. Richard S. Geary,PhD
  • Executive Vice President and Chief Development Officer
  • 2.31M
  • Dr. C. Frank Bennett,PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Kyle Jenne
  • Executive Vice President, Commercial
  • --
  • Eric E. Swayze, PhD
  • Executive Vice President, Research
  • 2.12M
  • Brian Birchler
  • Executive Vice President, Corporate and Development Operations
  • --
  • Dr. Joseph Loscalzo
  • Chairman of the Board
  • 597.70K
  • B. Lynne Parshall, Esq.,J.D.
  • Director
  • 812.34K
  • Michael J. Yang
  • Director
  • --
  • Joan E. Herman
  • Independent Director
  • 562.20K
  • Joseph Klein, III
  • Independent Director
  • 592.84K
  • Dr. Spencer R. Berthelsen,M.D.
  • Independent Director
  • 577.70K
  • Allene M. Diaz
  • Independent Director
  • 569.74K
  • Joseph H. Wender
  • Lead Independent Director
  • 627.70K
  • Dr. Michael Hayden, Ch.B.,M.B.,PhD
  • Independent Director
  • 575.84K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg